Moberg Pharma AB (publ) (MOB) — Capital Reinvestment Ratio
Latest as of December 2025:
1.00x
Moberg Pharma AB (publ) (MOB) has a Capital Reinvestment Ratio of 1.00x as of December 2025, meaning it reinvests 1% of its operating cash flow (Skr1.52 Million) in capital expenditures (Skr1.52 Million). See Moberg Pharma AB (publ) free cash flow ratio to measure how efficiently the company converts operating cash flow to free cash.
Capital Reinvestment Ratio
1.00x
Capex / Operating Cash Flow
Operating Cash Flow
Skr1.52 Million
SEK
Capital Expenditures
Skr1.52 Million
SEK
Data as of
Dec 2025
Most recent filing
Moberg Pharma AB (publ) Capital Reinvestment Ratio (2012–2019)
This chart tracks Moberg Pharma AB (publ)'s Capital Reinvestment Ratio across 6 annual periods.
Annual Capital Reinvestment Ratio for Moberg Pharma AB (publ) (2012–2019)
Year-by-year Capital Reinvestment Ratio for Moberg Pharma AB (publ) from 2012 to 2019. For live market cap and broader valuation context, see Moberg Pharma AB (publ) (MOB) total market value.
| Year | Reinvestment Ratio | Operating CF (SEK) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2019 | 0.73x | Skr3.95 Million | Skr2.87 Million | ▼ -35.8% |
| 2018 | 1.13x | Skr73.89 Million | Skr83.64 Million | ▲ +209.6% |
| 2017 | 0.37x | Skr53.82 Million | Skr19.68 Million | ▼ -74.4% |
| 2015 | 1.43x | Skr30.72 Million | Skr43.88 Million | ▲ +217.5% |
| 2014 | 0.45x | Skr16.16 Million | Skr7.27 Million | ▲ +576.8% |
| 2012 | 0.07x | Skr9.48 Million | Skr630.00K | — |
Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow